已收录 268921 条政策
 政策提纲
  • 暂无提纲
Proposal of ‘reactive-lymphocyte/histiocyte rich large B-cell lymphoma’ as an alternate term for ‘nodular lymphocyte predominant Hodgkin lymphoma’ that would also address its overlap with T-cell/histiocyte rich large B-cell lymphoma
[摘要] In the WHO classification, Hodgkin lymphoma is broadly classifiedas nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) andclassic Hodgkin lymphoma (CHL) [1].While this approach has served uswell for many years, there is renewed thinking as to whether ‘NLPHL’should be excluded from Hodgkin lymphoma. The reasoning comesfrom – (1) the overlap and biological relatedness to T-cell/histiocyterich large B-cell lymphoma (THRLBCL); and (2) the distinctiveness ofthe neoplastic cells of NLPHL from CHL [2]. If these reasons are valid,what would be the appropriate term that would address the issues andcapture the characteristic features.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词]  [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文